Literature DB >> 6549416

Protein C antigen is not an acute phase reactant and is often high in ischemic heart disease and diabetes.

S Viganò, P M Mannucci, A D'Angelo, C Gelfi, G F Gensini, C Rostagno, G G Neri Serneri.   

Abstract

Protein C, an antithrombotic protein, was measured immunologically in 299 patients with clinical conditions associated with a high frequency of venous or arterial thromboembolism. The mean protein C antigen (PC:Ag) level was high for 48 patients with ischemic heart disease and, to a lesser extent, for 95 diabetics. In 28 patients with thrombotic strokes, 48 patients with proximal deep-vein thrombosis and in 80 patients with localized or metastatic tumors, mean PC:Ag was normal. Comparison of the pattern of changes of PC:Ag levels with those of fibrinogen, orosomucoid and prothrombin in 21 patients during the postoperative period and in 20 patients with active rheumatoid arthritis ruled out the possibility that high PC:Ag is non-specific, acute-phase reaction to inflammation, tissue injury or neoplastic growth. Therefore, high PC:Ag might be specifically related to the thrombotic tendency of these patients, but the mechanism of such a relationship remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6549416

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.

Authors:  A Mormile; M Veglio; G Gruden; M Girotto; P Rossetto; P D'Este; P Cavallo-Perin
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

2.  Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.

Authors:  Adrienne Tin; Morgan E Grams; Nisa M Maruthur; Brad C Astor; David Couper; Thomas H Mosley; Myriam Fornage; Rulan S Parekh; Josef Coresh; Wen Hong Linda Kao
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-17       Impact factor: 8.237

3.  Anticoagulant protein C activity in non-insulin-dependent diabetic patients with normoalbuminuria and microalbuminuria.

Authors:  M Veglio; G Gruden; A Mormile; M Girotto; P Rossetto; P D'Este; P Cavallo-Perin
Journal:  Acta Diabetol       Date:  1995-06       Impact factor: 4.280

4.  [Immunologic and functional protein C determination in various internal diseases].

Authors:  K H Zurborn; H Broers; W Kirch; N Jäger; H D Bruhn
Journal:  Klin Wochenschr       Date:  1987-10-01

5.  Factor IXi-antithrombin (IXiAT) and thrombin-antithrombin (TAT) complexes in lung cancer patients.

Authors:  B Kemkes-Matthes; H Bleyl
Journal:  Ann Hematol       Date:  1992-01       Impact factor: 3.673

6.  Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients.

Authors:  P Knöbl; G Schernthaner; C Schnack; P Pietschmann; A Griesmacher; R Prager; M Müller
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

7.  Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features.

Authors:  Alberto Zanetto; Henry M Rinder; Elena Campello; Graziella Saggiorato; Yanhong Deng; Maria Ciarleglio; Francis P Wilson; Marco Senzolo; Sabrina Gavasso; Cristiana Bulato; Paolo Simioni; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2020-10       Impact factor: 17.425

8.  Utility of current thrombophilia screening in young patients with stroke and TIA.

Authors:  Vafa Alakbarzade; Alice Taylor; Marie Scully; Robert Simister; Arvind Chandratheva
Journal:  Stroke Vasc Neurol       Date:  2018-09-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.